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Abstract
The surge in antimicrobial resistance coupled with the decline in the antimicro-
bial drug pipeline calls for the discovery and development of new agents to tackle 
antibiotic resistance and prevent a return to a post-antibiotic era. Several factors 
account for resistance of microbes; some are natural and others are acquired. 
Natural selection, presence of efflux pumps, impermeable cell wall, biofilm forma-
tion and quorum sensing are some of the factors. Though it is difficult to outwit 
the pathogens, the discovery and development of compounds with pleiotropic 
modes or mechanisms of action different from the conventional drugs currently 
being used can help us tackle antimicrobial resistance. Natural products have been 
known to be a rich source of bioactive compounds with diverse structures and 
functional group chirality. Various reports indicate medicinal plants with antibac-
terial, anti-biofilm, efflux pump inhibition, wound healing effects or properties 
and others used for upper respiratory and urinary tract infections. There is an 
urgent need to research into natural products particularly plants for antimicrobial 
agents including antibacterial agents, anti-biofilm agents, antibacterial natural 
compounds and antibacterial chemicals. This chapter throws more light on such 
antimicrobials.
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1. Antibacterial agents
1.1 Introduction
The last decade has seen in a dramatic fashion, an accelerated microbiological 
evolution and resistance to antimicrobial agents. There is therefore the need to 
optimize appropriate stewardship of infection control in the light of an apparent 
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stagnation in the development of novel antimicrobial agents. This chapter therefore 
considers current anti-infective agents of the various classes that are clinically used 
in treating infections.
1.2 Beta lactam derivatives
The beta lactam derivatives stand as the oldest class of antibiotics used. The beta 
lactam ring has proven to be the major weapon in the fight against bacterial infections. 
Several novel molecules modeled after Alexander Fleming’s penicillin and its deriva-
tives have been developed. These drug moieties share the common characteristic of the 
beta lactam ring being an integral part of the structural make up and its effectiveness. 
These include the cephalosporins, monobactams, cephamycins, and the carbapenems 
(imipenem and meropenem). Beta lactams are indicated for a varied number of 
bacterial infections ranging from respiratory and urinary tract infections, ear and 
eye infections and gonorrhea to more life-threatening conditions like meningitis, 
septicemia and pneumonia. It is also widely adopted for prophylactic use in bacterial 
endocarditis, surgical site infections and in immuno-compromised situations [1].
Beta lactam antibiotics are bactericidal in their action. They inhibit the building 
of bacterial cell wall by interfering with the synthesis of peptidoglycan. Penicillin 
binding proteins which are bacterial enzymes which are essentially for bacterial 
cell wall synthesis are usually the targets of beta lactams [1]. Beta lactam antibiotics 
are generally available for parenteral administration with some also showing good 
absorption from the gastrointestinal tract. In patients with intact renal function, 
most beta lactams have a serum half-life of 1–2 h. Ceftazidime and temocillin break 
off this usual norm with a half-life of 4–6 h and an even higher half-life of 8–10 h 
for ceftriaxone. Penicillins and cephalosporins are eliminated primarily through 
glomerular filtration with varying levels of active transport across the renal tubules 
as well as the hepatobiliary system [2].
Owing to the general abuse of antibiotics, the beta lactams have suffered the 
challenge of the development of resistance in target pathogenic organisms. The pro-
duction of beta lactamases has been a major determinant in the resistance observed 
especially in Gram-negative pathogens. Alterations in the beta-lactam targets, the 
penicillin binding proteins, are also important in Gram-positive pathogens. Efflux 
mechanisms and/or exclusion of these agents also contribute more often in conjunc-
tion with the other two mechanisms [3]. New agents of the beta-lactam group that 
have been approved following development have come from the cephalosporin class.
1.3 Cephalosporins
Cephalosporins are usually classified based on spectrum, generation, chemi-
cal structure, clinical pharmacology and resistance to beta-lactamases. The first 
cephalosporins were assigned first-generation cephalosporins; later, more expanded 
spectrum cephalosporins were designated as second-generation cephalosporins. 
Each more current generation has altogether more prominent activity against 
Gram-negative bacteria than the preceding generation and much of the time with 
diminished action against Gram-positive bacteria. Fourth-generation cephalospo-
rins, however, have true broad-spectrum activity. The recent addition to the block, 
the fifth generation cephalosporins has become very crucial due to its activity 
against multidrug-resistant Staphylococcus aureus (MRSA) [4].
The drug of choice in this latest generation is ceftaroline. It is the only beta-
lactam with MRSA activity. Ceftaroline, which is available as a pro-drug, ceftaroline 
prosamil is again unique for its expanded and extensive Gram-positive activity 
beyond all presently available cephalosporins. Ceftaroline active against the 
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Gram-positive organisms (Streptococcus pneumoniae, Staphylococcus aureus and 
Streptococcus pyogenes) and Gram-negative species (Haemophilus influenzae and 
Moraxella catarrhalis), including resistant phenotypes. Data for its approval proved 
its effectiveness in the treatment of acute bacterial skin and skin structure infec-
tions and community acquired bacterial pneumonia [5]. Ceftaroline demonstrates 
dose-proportional pharmacokinetics similar to other renally excreted cephalosporins 
after intravenous administration. It is half-life after dose is 2.53 h with protein bind-
ing of approximately 20%. Ceftaroline also showed in clinical trials to have positive 
attributes with regards to antibacterial stewardship by having a low potential for 
development of resistance as well as favorable tolerability and safety profile [5].
Ceftolozane is a novel beta-lactam cephalosporin combined with beta-lactamase 
inhibitor, tazobactam for the management of complicated urinary tract and intra-
abdominal infections. The peculiar chemistry and dosing accounts for its extensive 
coverage of Gram-negative organisms including multidrug-resistant Pseudomonas 
aeruginosa as well as extended-spectrum beta-lactamase producing organisms and 
some anaerobes. Its efficacy can be compared to levofloxacin in patients with com-
plicated urinary tract infections, including pyelonephritis, and comparable to that of 
meropenem against complicated intra-abdominal infections. Ceftolozane-tazobactam 
has shown to be indispensable due to the lack of susceptibility to the usual mechanisms 
of resistance mostly by Gram-negative organisms such as the production of beta-lacta-
mases, efflux pumps, alterations in penicillin binding proteins as well as porin loss [6].
1.4 Glycopeptides
Glycopeptide antibiotics are complex and rigid molecules that repress a late 
stage in bacterial cell wall peptidoglycan synthesis. The selective toxicity of 
glycopeptides is attributable to the fact that its 3D structure harbors a cleft into 
which peptides of a specific configuration found only in bacterial cell walls can fit. 
Glycopeptide has assumed a special role in the face of the general threat of antimi-
crobial activity resistance since its unique mechanism involving the attachment of a 
bulky inhibitor to a substrate with the goal that the active sites enzymes are unable 
to align themselves correctly, therefore renders resistance to glycopeptides more 
difficult to achieve than other antimicrobial agents [7].
A good number of glycopeptides have gone through development in recent years 
and have been approved for clinical use. Oritavancin, a lipoglycopeptide obtained from 
the naturally occurring chloroeremomycin of the eremomycin class of glycopeptides is 
very similar to vancomycin but possess two 4-epi-vancosamine monosaccharides, one 
supplanting vancosamine and the other connected to ring-6 via an amino acid residue. 
Based on the features of its pharmacophore and its stereochemistry, it has enhanced 
antimicrobial against Gram-positive organisms including those possessing both VanA- 
and VanB-mediated vancomycin-resistance [8]. Oritavancin is transcendently cleared 
by means of the reticuloendothelial system, accumulating most notably in macro-
phages of the liver (Kupffer cells), kidney, spleen and lungs, as well as in the intestinal 
mucosa, thymus, and lymph nodes. Subsequent release and elimination from these 
tissues does not occur readily and thus only trace amounts are recouped from urine 
and feces. Dosage adjustments are not required in hepatic and renal insufficiency [9].
Telavancin also derivative of vancomycin and a lipoglycopeptide has been shown 
to have a dual mechanism of action by causing an inhibition of the peptidoglycan 
synthesis and through membrane depolarization. Telavancin is reliably active 
against Staphylococcus aureus, including MRSA, vancomycin-intermediate-resistant 
Staphylococcus aureus, linezolid-resistant Staphylococcus aureus, and daptomycin-
susceptible strains and therefore effective for the treatment of complicated skin and 
skin-structure infections. It has additionally proven effective in the treatment of 
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Gram-positive bacterial infections especially pneumonia. Its non-inferiority is com-
pared with vancomycin, in the treatment of complicated skin and skin-structure 
infections and pneumonia. Telavancin is excreted by the kidneys, and thus, dosage 
adjustments are required in cases of renal failure. Telavancin is related with higher 
rates of renal events, changed taste, nausea and vomiting but however lesser rates of 
pruritus and infusion related events relative to vancomycin [10].
Dalbavancin has proven to be a valuable addition to the armamentarium of 
antimicrobial agents as it is the first once a week antibiotic with activity against 
a broad range of Gram-positive pathogens. Dalbavancin’s uniqueness is its novel 
pharmacokinetic profile with a half-life of 170–210 h, which makes the once-weekly 
dosing optimal. Forty percent is eliminated via the renal route. Most of the drug is 
excreted as intact drug. Concentration was unchanged in patients with mild renal 
impairment. No adjustments are needed in hepatic insufficiency, as concentrations 
of the drug do not increase with severe hepatic impairment. It is still unknown if 
the drug penetrates the cerebrospinal fluid, or whether the drug is removed during 
hemodialysis. However, the high protein binding of dalbavancin would suggest both 
of these scenarios to be unlikely [11].
1.5 Oxazolidinones
Oxazolidinones are synthetic antimicrobial agent which inhibit bacterial pro-
tein synthesis. Linezolid, the first oxazolidinone to be approved for clinical use, 
has bacteriostatic activity against many important resistant pathogens including 
methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, 
and penicillin-resistant Streptococcus pneumoniae as seen from in vitro studies 
[12]. Tedizolid which is available as a prodrug (tedizolid phosphate) is the first in 
the class to be dosed once daily as it has a half-life of 12 h. It also has a profound 
oral bioavailability of about 90% and no dosage adjustment is required between 
intravenous and oral administration, nor is dosage adjustment needed based on 
hepatic or renal impairment. Its activity covers Gram-positive pathogens, includ-
ing methicillin-resistant Staphylococcus aureus. It is indicated for the management 
of acute bacterial skin and skin structures infections. Tedizolid appears to depart 
from linezolid in the incidence of gastrointestinal and hematologic side effects 
and the apparent lack of drug interaction with selective serotonin reuptake 
inhibitors [13].
1.6 Fidaxomicin (macrocyclic antibiotics)
Fidaxomicin is the first in the new class of narrow spectrum macrocyclic antibiot-
ics. It is derived from the organism Dactylosporangium aurantiacum as a fermenta-
tion product. Fidaxomicin’s action leads to an inhibition transcription process by 
interfering with RNA polymerase. Fidaxomicin acts at a distinct site and step of RNA 
synthesis to that of the rifamycins and streptolydigin, and thus no overlapping anti-
biotic resistance has been identified. Its narrow spectrum of activity is against most 
Clostridial spp., including Clostridium difficile, and exhibits moderate activity against 
other Gram-positive organisms, such as staphylococci and enterococci. Systemic 
absorption is very limited with serum concentrations remaining generally low [14].
1.7 Aminoglycosides
Aminoglycosides are exceptionally potent, broad-spectrum antimicrobial 
agents with numerous alluring properties for the treatment of hazardous diseases. 
The antibacterial potency of the aminoglycosides is attributable to one or several 
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aminated sugars linked by glycosidic bonds to a dibasic cyclitol in their chemical 
structures. Aminoglycosides act primarily by impairing bacterial protein synthesis 
through binding to prokaryotic ribosomes. Widespread resistance against these 
agents including semi-synthetic additions such as amikacin and netilmicin has 
prompted the need for development of alternative agents. The three main resistance 
mechanisms identified include a decreased cell permeability; alterations at the 
ribosomal binding sites; and production of aminoglycoside modifying enzymes 
[12]. Plazomicin is a next-generation semisynthetic aminoglycoside derived 
from sisomicin, a naturally occurring aminoglycoside antibiotic. Plazomicin is 
active against Gram-negative and selected Gram-positive bacteria and it is active 
against enterobacteriaceae, multidrug-resistant enterobacteriaceae (MDR-EC), 
aminoglycoside-resistant enterobacteriaceae (AR-EC), carbapenem-resistant 
Enterobacteriaceae (CR-EC), colistin-resistant enterobacteriaceae (CRE), tige-
cycline-resistant enterobacteriaceae (TR-EC). It has no nephrotoxic and ototoxic 
effects that characterize agents in this class. Its superior pharmacokinetic profile 
also supports a more convenient once daily IV dosing [15].
1.8 Pleuromutilins
Pleuromutilins are antimicrobial agents that selectively restrain bacterial trans-
lation and derivatives of the naturally occurring tricyclic diterpenoid pleuromu-
tilin. The interest in pleuromutilins has resurged following the resistance in more 
prominent classes like the beta-lactams. Pleuromutilins inhibit bacterial protein 
synthesis by binding to the central part of domain V of the 50S ribosomal subunit 
at the peptidyl transferase center ultimately affecting peptide bond formation [16]. 
Retapamulin used as a topical agent for the treatment of impertigo has bacterio-
static effect against Staphylococcus aureus and Streptococcus pyogenes. Retapamulin is 
well tolerated with the most commonly reported adverse effect being pruritus at the 
application site. Although comparative efficacy has not been established with mupi-
rocin, it is an effective alternative with dosing advantage of twice a day application.
1.9 Tetracyclines
The tetracyclines are another old class of natural product antibiotics. Until the 
development of doxycycline, they were used topically. However subsequent sys-
temic application allowed for its use in the treatment in respiratory tract infections. 
Tetracyclines also inhibit protein synthesis by inhibiting acyl-tRNA transfer on the 
bacterial 30S ribosome. Tetracyclines have a fused linear tetracyclic structure and 
form chelation complexes with divalent cations such as calcium and thus its use has 
been limited to adults albeit with side effects. They usually serve as alternative to 
patients who are intolerant of macrolides or macrolide-resistant pathogens [12].
Tigecycline is the foremost drug in the new glycycline subclass of antibiotics. In 
spite of the fact that it is structurally identifies with minocycline, modifications to 
the molecule has brought about an expanded spectrum of activity and decreased 
susceptibility to the development of resistance when compared with other tetra-
cycline antibiotics. Tigecycline has a broad spectrum of activity, including activity 
against drug-resistant Gram-positive organisms [17].
1.10 Macrolides
Macrolides which have erythromycin as its first member inhibit protein synthe-
sis by binding to the 23S RNA of the bacterial 50S ribosomal subunit at the exit of 
the peptide synthesis tunnel. Macrolides are most widely adopted for respiratory 
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tract infections as they have targeted activity against respiratory pathogens. 
Macrolide antibiotics achieve high tissue and intracellular concentrations, which 
helps to address bacteria that are intracellular. In addition, they have strong anti-
inflammatory properties [12]. Telithromycin belongs to a class of drugs described 
as the ketolides which varies slightly from the existing class of the macrolides. 
The characteristic feature of the ketolides as opposed to other macrolides is the 
removal of the neutral sugar, L-cladinose from the three position of the macrolide 
ring and the subsequent oxidation of the 3-hydroxyl to a 3-keto functional group. 
Telithromycin is indicated for the treatment of upper respiratory tract infections 
such as community acquired pneumonia and sinusitis. Introduction of telithromy-
cin was opportune due to the rise of microbial resistance in the existing macrolides 
as it appears to be effective against macrolide-resistant bacteria such as macrolide-
resistant Streptococcus pneumoniae [18].
1.11 Quinolones
The quinolones although not obtained from microbial source, are derived indi-
rectly from natural products, i.e., as a by-product of chloroquine synthesis, which is 
in itself an analogue of the plant alkaloid quinine. It has established itself as useful in 
the treatment of urinary tract infections. The introduction of fluorine group to the 
core structure, give rise to the fluoroquinolones like ciprofloxacin and moxifloxacin 
yielded products of an improved spectrum and better pharmacokinetic profiles. 
However, resistance to the class of antibiotics whose mechanism of action is to inhibit 
bacterial DNA gyrase and topoisomerase IV and even newer fluoroquinolones has 
prompted the need for the development of new and effective agents [12]. Delafloxacin 
is a new anionic fluoroquinolone used for the treatment of acute bacterial skin and skin 
structure infections caused by Gram-positive and Gram-negative organisms including 
MRSA and Pseudomonas aeruginosa. As with all fluoroquinolones, resistance is medi-
ated through mutations in the target enzymes and drug efflux. However, delafloxacin 
has greater stability against target enzyme mutations in Gram-positive bacteria relative 
to other fluoroquinolones. Its availability in infusion and oral formulations, stability 
and enhanced antibacterial potency in acidic environments and overall tolerability 
gives a potentially better antimicrobial agent in the treatment of other infections [19].
2. Anti-biofilm agents
2.1 Biofilms
Microorganisms have a strong tendency to become associated with surfaces [20]. 
Bacteria, thus, live in communities, adhering to surfaces of implanted medical devices 
or damaged tissues. On these surfaces they encase themselves in a hydrated matrix of 
polysaccharide and protein forming a slimy layer known as biofilms [21]. Biofilm is 
a microbial culture which is identified as cells permanently bound to an interface or 
to other cells and are firmly attached to matrix consisting of polymers produced as a 
result of phenotypic alteration due to growth rate or transcription of genes. Bacteria 
tend to form biofilms in environments with rapid flow of matter. Planktonic bacteria 
can adhere to surfaces and initiate biofilm formation in the presence of shear forces 
that are higher than those of heart valves and exceed Reynolds numbers of 5000. The 
Reynolds number has no dimension and describes the turbulent flow of a liquid. If it 
is high, turbulent flow exists but if it is low then laminar flow conditions prevail. It 
is speculated that turbulent flow enhances bacterial adhesion to surfaces and biofilm 
formation by impinging the planktonic cells on the surface [22].
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Biofilms do not form only between same species of microorganism but there 
can be inter-species adhesions. Interspecies binding outside the oral cavity have 
been described as well, most notably between pathogenic and commensal micro-
organisms of the urinary tract. Co-aggregation between aquatic bacteria has been 
reported, with Micrococcus luteus being mentioned as a bridging organism in the 
development of aquatic biofilms owing to its ability to co-aggregate with many 
aquatic heterotrophs [20, 23].
2.2 Bacterial biofilm formation
Genes are responsible for noted biochemistry of living things and biofilm 
production is no exception. Changes in microbial colony formation and organi-
zation may be due to mutations in one or more of certain genes. Mutations in a 
gene called wspF, which is part of a putative chemosensory signal-transduction 
operon result in cell aggregation and altered colony morphology. The phenotypic 
characteristics of WspF depend on the presence of WspR, which is a member of a 
family of signal transduction proteins known as response regulators. WspR contains 
a glycine-glycine-aspartic acid-glutamic acid-phenylalanine (GGDEF) domain 
known to catalyze formation of a cytoplasmic signaling molecule cyclic diguanylate 
(c-di-GMP). Mass sequencing of genomes in bacteria detected the highly abundant 
protein domains GGDEF and Glutamic acid-Alanine-Leucine (EAl) [24]. These two 
protein domains are involved in the turnover of c-diGMP in vivo.
The GGDEF domain stimulates c-diGMP production whereas EAL stimulates its 
degradation. Increased cellular levels of c-diGMP has been observed to correspond 
to increased biofilm formation in a wspF mutant while increased levels of EAL 
catalyze degradation of c-diGMP and reversed the phenotypes of a WspF mutant 
and inhibited biofilm initiation by wild-type cells, indicating that the presence of 
c-diGMP is necessary for biofilm formation. The psl and pel operons, which are 
involved in exopolysaccharide production and biofilm formation, were expressed at 
high levels in a WspF mutant [25].
2.3 Stages of biofilm formation
The process of biofilm formation is complex, but generally identified as consist-
ing of five stages.
2.3.1 The conditioning film
The conditioning layer is the foundation on which a biofilm grows, and can 
be composed of many particles, organic or inorganic. Via gravitational pull or 
direction of flow of the bulk fluid, particles rest and become integral component 
of conditional layer. Hence, the conditioning layer which is basically made up of 
organic matter provides anchorage and nutrients for bacterial growth [26].
2.3.2 Reversible adhesion
When plankton bacteria come into close proximity with the conditioning 
layer, it attaches using bacteria appendages such as flagella, fimbriae, and pili. A 
fraction of the cells reaching the surface reversibly adheres. However, the abil-
ity of the plankton to adhere is dependent on factors such as available energy, 
bacteria orientation, temperature and pressure in the immediate environment. 
If repulsive forces are greater than the attractive forces, the bacteria will detach 
from the surface [26].
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2.3.3 Irreversible adhesion
A number of the reversibly adsorbed cells remain immobilized and become 
irreversibly adsorbed. It has been reported that the physical appendages of bacteria 
overcome the physical repulsive forces. Henceforth, the attachments do come in close 
proximity with the bulk lattice of the conditioning layer culminating in oxidation and 
hydration which strengthen the bacteria–surface bond. There is a data supporting 
the assertion that microbial adhesion intensely relies on the hydrophobic–hydrophilic 
nature of interacting surfaces [26].
2.3.4 Cell growth
With the adhered cells undergoing binary division, the resulting clonally 
expanded cells spread from the point of adhesion leading to clusters formation. 
Ideally, such growth occurring in the biofilm yields a mushroom-like arrangement. 
Nutrient supply to the bacteria present within the biofilm is made possible through 
the utilization of this mushroom-like assemblage. As the cells increase, they 
produce polysaccharide intercellular adhesion polymers which facilitate stronger 
attraction between adjacent cells [26, 27].
2.3.5 Final stages of biofilm development
As the bioburden increases, organisms enter into the stationary phase of growth 
cycle where the rate of cell division equals the rate of cell death. At this level of high 
population density, the bacteria cells interact with each other via signaling mecha-
nisms called quorum sensing, a good explanation for the role of auto inducers in the 
stimulation of the mechanical and enzymatic procedures through genetic expression.
Death phase entails the collapse of the formed biofilm. The bacteria culture 
produce enzymes which catalyze the catabolism of the structural polysaccharides 
within the biofilm leading to exposure of the bacteria within the matrix to colonize 
new substrates [26, 28].
2.4 Antibiotic resistance due to biofilm formation
Inside biofilms, organisms resist antibiotic action by multicellular strategies, rather 
than the known genetic processes that involve plasmids, transposons and mutations 
that make individual cells resistant [29]. Biofilms are the root cause of many persistent 
chronic infections due to bacteria. Several organisms have been known to produce 
biofilms. In P. aeruginosa, it has been shown that the gene (algC) that controls phos-
phomannomutase involved in alginate (exopolysaccharide) synthesis is up-regulated 
within minutes of adhesion to a solid surface. It has also been shown that algD, algU, 
rpoS and the genes controlling polyphosphokinase synthesis are all up-regulated 
during biofilm formation [22]. Multi-system that includes poor antibiotic penetra-
tion, nutrient limitation and slow growth, adaptive stress responses, and formation of 
persister cells are hypothesized to constitute the organisms’ resistance to antibiotics 
in biofilms [29]. Organisms that have shown resistance to antibiotics as a result of 
biofilm production include Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia 
coli, Pseudomonas pseudomallei, and Streptococcus sanguis [22].
Susceptibility tests with in vitro biofilm models have shown the survival of bac-
terial biofilms after treatment with antibiotics at concentrations hundreds or even 
a thousand times the minimum inhibitory concentration of the bacteria measured 
in a suspension culture indicates a state of a high resistance to antibiotics [30]. 
Antibiotics used for the treatment of such bacterial infections suppress symptoms 
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of infections by killing free-floating bacteria shed from the attached population, 
but fail to eradicate those bacterial cells still embedded in the biofilm. The biofilm, 
thus, offers protection to the organisms from the effects of the antibiotics. After the 
treatment course of the infection, the biofilm can act as a microbial repository for 
recurrence of infection. Biofilm infections can linger on for months, years, or even a 
lifetime as long as the colonized surface is not removed from the body [29].
In biofilms, the familiar mechanisms of antibiotic resistance such as efflux 
pumps, modifying enzymes, and target mutations do not account for the resistance 
of the organism and protection of bacteria in a biofilm. Even sensitive bacteria 
that do not have a known genetic basis for resistance can have profoundly reduced 
susceptibility when they form a biofilm. The fact that all these antibiotic resistance 
mechanisms are inherently multicellular helps to explain why bacteria dispersed 
from biofilms rapidly revert to a susceptible phenotype [31]. Although they are less 
common, fungal biofilms are also found on implanted medical devices. Candida 
albicans biofilms are drastically very resistant to most antifungal drugs, and are a 
major cause of morbidity in blood-stream infections [32, 33].
2.5 Other effects of biofilms
Biofilms can be both beneficial and detrimental. They are beneficial in the 
degradation of environmental hazardous substances in the soil, in a bioreactor and 
as bio-flocculants in the separation of coal particles from associated mineral matter. 
They are detrimental on food and slaughterhouse equipment, ship hulls, biomateri-
als implants, and in the oral cavity [20]. They are implicated in otitis media [34], 
otolaryngologic infections [35], osteomyelitis [36], bacterial endocarditis [37], 
cystic fibrosis and nonhealing wounds [38].
When organisms are in biofilms, they tend to cause infections with similar 
features although there could be significant variations in the causative organisms. 
Importantly, bacterial biofilms tend to bypass host defense mechanism and can 
withstand drug treatment irrespective of the competence of the individual’s immune 
system. Actually, tissues adjacent to the biofilm might undergo collateral damage by 
immune complexes and invade the neutrophils [29]. Biofilms have also been docu-
mented as the major sources of infection by Candida albicans, specifically in view 
of the vast number of biomaterials that are now being used in the medical industry. 
Biomaterials serve as ideal substrates for microbial adhesion and eventual biofilm 
formation. Such materials include stents, catheters, and orthopedic joints [39].
2.6 Biofilm formation inhibitors
Prevention of biofilm formation or countering the resistance mechanisms due 
to biofilms may simplify the treatment of infections caused by biofilm producing 
organisms and bring back the usefulness of antibiotics that are out of use due to bio-
film resistance [29]. Many substances, both natural and synthetic, have been found 
to inhibit biofilm formation. For example, silver nanoparticles (AgNPs) effectively 
prevent the formation of biofilms and kill bacteria in established biofilms produced 
by clinical strains including Acinetobacter baumannii and Pseudomonas aeruginosa, 
methicillin-resistant Staphylococcus aureus (MRSA) and Streptococcus mutans. Anti-
biofilm formation activity of AgNPs was more pronounced on Gram-negative than 
Gram-positive bacteria although both groups exhibit equal antibacterial activity to 
the substance. AgNPs also inhibit biofilm production by Candida albicans [40]. The 
helical human cathelicidin LL-37 exhibits effective antimicrobial, anti-attachment, 
and anti-biofilm activity against Staphylococcus aureus [41]. Some plants have also 
been found to inhibit biofilm formation. Extracts of the sticks of Salvadora persica 
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has been reported for its antibacterial and anti-biofilm activities against Streptococcus 
mutans [42]. Essential oils of lemon grass have biofilm inhibition activity against S. 
aureus [43] while the essential oils of Boswellia spp. (B. papyrifera and B. rivae) are 
active against staphylococcal and C. albicans biofilms [44].
2.7 Detection of biofilms
Various methods have been used to determine the presence of biofilms produced 
by bacteria. The methods include tissue culture plate method (TCP), tube method 
(TM), Congo red agar method (CRA), bioluminescent assay, piezoelectric sensors, 
and fluorescent microscopic examination. In the tube method a loopful of overnight 
culture of the test organism is inoculated into trypticase soy broth containing 1% glu-
cose and incubated. The bacterial cultures are poured out of the solution and the tubes 
washed using phosphate buffer saline and dried. The dried tubes are stained with 
0.1% crystal violet with the excess stained washed with deionized water. The tubes are 
dried while inverted with observation made for biofilm formation which confirmed 
by the presence of visible film lining the wall as well as the bottom of the tube. If there 
is an observed ring-like development at the liquid interface it does not indicate biofilm 
formation [45]. In the Congo red agar method, the test organism is grown in red Congo 
agar on Brain heart infusion broth containing Congo red dye (0.8 g/L). The appear-
ance of black colonies with a dry crystalline consistency indicated biofilm formation 
[45, 46]. In the tissue culture plate method a 24-h broth culture of the test organism is 
inoculated into trypticase soy broth (TSB). This primary inoculum is then inoculated 
into TSB with 1% glucose prepared in different dilutions (1:20, 1:40, 1:80 and 1:100) 
and loaded into 96 wells flat bottom microtiter plate, which is an abiotic surface. The 
plate is then incubated at 37°C for 24 h. The content of the wells are decanted and 
washed with phosphate buffer, fixed with methanol for 15 min and decanted. They are 
then stained with crystal violet (0.5%) for 20 min, decanted and washed with distilled 
water. Glacial acetic acid is then added to extract the crystal violet and the optical 
density determined at 490 nm using an ELISA plate reader [45].
3. Antibacterial natural products
3.1 Introduction
Natural products play a significant role in the discovery of lead compounds for 
the development of drugs for the treatment of human diseases. The importance 
to medicine of natural product molecules lies not only in their pharmacological or 
chemotherapeutic effects but also in their role as template molecules for the produc-
tion of new drug substances. Nature in one way or another continues to influence 
the design of small molecules and most of the antibacterial drugs in clinical usage 
are naturally derived.
Natural products have the ability to provide diversity, complexity, novelty and 
new scaffolds with various chiral centers, rings, bridges and functional groups in 
the molecule [47]. They differ from synthetic compounds by having more oxygen 
atoms and stereochemical elements such as polycycle (often bridged) carbon skel-
etons [48, 49]. Some of the most valuable products and promising leads in oncology 
were naturally derived or naturally inspired. For instance paclitaxel a chemically 
established drug came from natural sources. Doxorubicin, camptothecins, and 
tamoxifen derived from natural product leads, steroid hormones. Most of the 
promising pipeline candidates in oncology all arose from natural products screening 
followed by synthetic modifications.
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3.2 Examples of antibacterial natural products
Antibacterial natural compounds include secondary metabolites isolated from 
plants, bacteria, fungi, marine organisms and algae. These compounds are categorized 
based on their chemical type as terpenes (sesquiterpenes, diterpenes, sesterterpenes, 
and triterpenes), steroids (sterols), alkaloids (indole, quinoline, pyridoacridone, and 
amine alkaloids), aromatics (flavonoids, chalcones, coumarins, lignans, xanthones, 
anthracenes, anthraquinones, naphthalene), polyketides (acetylenic fatty acids, 
polycyclic esters and quinones), and peptides. Sometimes, the categorization tends to 
put together structurally relevant natural products with low bioactivity and also those 
synthetic analogues with remarkable antibacterial activity [47].
Since there is a continual need for a pipeline of new agents to combat multidrug-
resistant bacteria, it is important the search goes on especially from plant materials. 
Microbially derived products, of which there are many first class drug examples 
which can be readily fermented with few re-supply issues [50]. The value of natural 
products as a screening resource has recently been highlighted and it is likely the 
focus is on plants, microbes and marine organisms [51].
Examples of antibacterial natural products include cranberry juice Vaccinium 
macrocarpon (family: Ericaceae) which is used in the management of urinary 
tract infections and the prevention of recurrent cystitis. Berberine has antibacte-
rial activity against various strains of methicillin resistant Staphylococcus aureus 
(MRSA). Thymol is used as an antiseptic. Bearberry, Arctostaphylos uva-ursi L. 
(family: Ericaceae) is an antimicrobial agent used particularly for urinary tract 
infections against several organisms including Bacillus subtilis, Escherichia coli, 
Mycobacterium smegmatis, S. aureus and Shigella spp. and the antibacterial activity 
is attributed to arbutin. Lemon balm, Melissa officinalis (family: Lamiaceae) and 
tea tree, Melaleucae alternifolia (family: Myrtaceae) are taken as herb teas and 
tea tree oil is applied as ointment [51]. Garlic, Allium sativum (family: Alliaceae) 
have antimicrobial and antiseptic properties and is used for respiratory tract 
infections [48, 49] .
Tannins and resins produced by plants have antimicrobial and wound-healing 
properties. The essential oil constituents of plants also possess antimicrobial activ-
ity. Plants produce phytoalexins in response to infections caused by fungi viruses 
and bacterial that may infect them. Resveratrol is an example of an antifungal 
phytoalexin, which has anticancer, antioxidant and cardioprotective benefits for 
humans. Plant metabolites with antibacterial properties include anti-staphylococcal 
activities of the acylphloroglucinols and terthiophenes [47].
The quest for newer and potent antimicrobial agents has ventured into studies 
on plants in this research driven direction. It, however, makes a cogent argument 
since plants are known to produce varied chemicals for defense purposes against 
microorganisms. Also they produce cytotoxic compounds some of which have 
been successfully utilized as chemotherapeutic agents and hence give a laudable 
reason to continue with search for new treatment protocols for man. There is also 
an ecological rationale for the production of natural products that modify microbial 
resistance. Plants may have evolved compounds which evade MDR mechanisms 
and that plant antimicrobials might be developed into broad-spectrum antibiotics 
in combination with inhibitors of MDR [52]. These MDR proteins are commonly 
found in nature as efflux pumps for foreign toxic substances, as they are in clinical 
isolates of resistant pathogens.
In the food industry, herbs, spices and essential oils are chiefly employed as pre-
servatives of foods. A number of plants and spices are used as antimicrobial agents 
for killing and decreasing pathogenic bacterial load in foods hence improving its 
quality. These plant-based antimicrobials are produced from various extraction 
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techniques using the flowers, buds, seeds, leaves, twigs, bark, herbs, wood, fruits 
and roots of various plants [50, 51].
4. Non-medicinal antibacterial chemicals
An ideal antibacterial agent (medicinal or non-medicinal) tends to have char-
acteristics, which include ability to effectively inhibit or kill bacteria. Also it must 
have appreciable solubility either in water or any suitable solvent [53]. Antibacterial 
chemicals should be stored for a reasonable period of time with no significant loss 
of antibacterial action [54]. Such preparation must also be homogeneous with 
the active ingredients present in each application of the non-medicinal chemical 
against bacteria. An antibacterial chemical should be minimally inactivated when 
exposed to extraneous material such as proteins and other organic materials found 
in substances they are being utilized in treating. This decreases the amount of the 
agent the bacteria are exposed to [55, 56]. Antibacterial chemicals should not neces-
sarily require elevated temperatures beyond that of the environments they are being 
used [57]. Again, such ideal antibacterial chemicals do possess cleansing properties, 
must be either odorless or have pleasant odor [58] and should be physically safe on 
surfaces they are used on.
The antimicrobial activities of these chemicals are often strongly influenced by 
the biocide affinity for the structural or molecular components of the cell, which 
can, in turn, depend on the attraction of dissimilar charges or hydrophobic interac-
tions [53, 59]. It is henceforth convenient to consider the modes of action based on 
biocides target on the bacteria. Some probable drug target to be exploited include the 
cell wall, cell membrane and the cytoplasm. The precise mechanism of antimicrobial 
action of some of these agents will be discussed in this section as well as unraveling 
the concentration-dependent multiplicity in action of some of these agents [57].
4.1 Alcohols
Two water-soluble alcohols, i.e., ethyl alcohol and isopropyl alcohol, are nor-
mally employed as disinfectants due to their high germicidal activity [60]. They 
have rapid bactericidal and bacteriostatic activity against vegetative forms of 
bacteria. Although not active against bacterial spores, their tuberculocidal, fun-
gicidal and virucidal activity are also apparent. Their cidal activity drops sharply 
when diluted below 50% concentration, and the optimum bactericidal concentra-
tion is 60–90% v/v solutions in water [60, 61]. Protein denaturation is the most 
likely cause of the alcohol action. This assertion is affirmed by the realization of 
the reduced bactericidal activity of absolute ethyl alcohol when compared with 
hydroalcohol due to the requirement of water to facilitate the protein denatur-
ation process [62, 63]. This observation is also in conformation with the observed 
destruction of dehydrogenases of Escherichia coli by alcohol [64] and also the 
enhancement of the lag phase of Enterobacter aerogenes by alcohol [65] which is 
however reversed with some amino acids. Blockade of metabolites required for cell 
division has been linked to the bacteriostatic action of alcohol.
The role of hydrophobic alkyl groups of long-chain alcohols in antibacterial activ-
ity against Staphylococcus aureus and Propionibacterium acnes has been established 
[66]. The maximum activity was found to be dependent on the chain length from 
the hydrophilic hydroxyl group, and also the test bacteria. The antimycobacterial 
activities of alcohols with chain length ranging from C5 to C13 against Mycobacterium 
smegmatis mc2155 and M. tuberculosis H37Rv have been established, with best activity 
found with alcohol with C10 chain length [67]. This bactericidal activity is attributed 
13
Antimicrobial Agents: Antibacterial Agents, Anti-biofilm Agents, Antibacterial Natural…
DOI: http://dx.doi.org/10.5772/intechopen.82560
to decanol’s potential to harm the robust and complex cell envelope of Mycobacteria 
and its ability to reduce biofilm formation by M. smegmatis [67].
4.2 Aldehydes
The aqueous solutions of some aldehydes, such as formaldehyde and glutaral-
dehyde, have been found to be bactericidal, tuberculocidal, fungicidal, virucidal, 
and sporicidal [68–70]. Formaldehyde inactivates microorganisms by alkylating the 
amino and sulfhydryl groups of proteins and ring nitrogen atoms of purine bases 
[71]. The biocidal activity of glutaraldehyde results from its alkylation of sulfhy-
dryl, hydroxyl, carboxyl, and amino groups of microorganisms, which alters RNA, 
DNA, and protein synthesis [72].
Studies have established that different concentrations of formaldehyde have 
deleterious effect on a lot of microorganisms. It has been realized that 8% formalin 
can inactivate poliovirus in 10 min although other viruses are inactivated by as 
low as 2% formalin [68]. Tuberculocidal potential can be seen with 4% formalin 
with the agent being able to inactivate 104 Mycobacterium tuberculosis cells with 
2 min [69]. Also, about 10 million Salmonella typhi cells can be inactivated by 2.5% 
formaldehyde within 10 min even in the presence of organic matter [70]. However, 
formaldehyde has significantly reduced sporicidal activity than glutaraldehyde as 
seen from experimental studies [69].
Some aliphatic saturated and unsaturated aldehydes are produced by enzymatic 
cleavage of unsaturated fatty acids when plants undergo microbial attack; thus 
they may be one of the multichemical defense mechanisms used by several fruits to 
resist invasion by microorganisms [73]. In this direction, Trombetta and colleagues 
established the mechanism of the antimicrobial activity of aliphatic α,β-unsaturated 
aldehydes which included (E)-2-hexenal (1), (E)-2-eptenal (2), (E)-2-octenal (3), 
(E)-2-nonenal (4), (E)-2-decenal (5) and (E,E)-2,4-decadienal (6) (Figure 1). Their 
findings suggested that the 2E-alkenals tested elicit, very likely, a gross perturbation of 
the lipidic fraction of plasma membranes and are able to penetrate into bacterial cells.
The mechanisms of antimicrobial action of other aldehydes, such as o-phthal-
aldehyde (7), are likely to involve interaction with the cytoplasmic membrane and 
increase in its permeability [74, 75]. o-Phthalaldehyde also appears to kill spores 
by blocking the spore germination process [76]. Although membrane functional 
proteins are generally supposed to be the potential targets toward which aldehydic 
antimicrobial agents are directed, other mechanisms of action/interaction can help 
explain their antimicrobial activity [73].
Figure 1. 
Aldehydes with antibacterial properties.
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Figure 2. 
Oxidizing agents with antibacterial activity.
4.3 Halogens
Over the years, tinctures and solutions of iodine have been used mainly as 
antiseptic agents on skin surfaces and other tissues. However, iodophors such 
as povidone iodine, are employed mainly as antiseptics and disinfectants. Such 
iodophors tend to possess germicidal ability but generally do not stain surfaces as 
well as do possess less toxic and irritant potential [77]. Iodine has the potential to 
penetrate the cell wall of microorganisms rapidly and tend to compromise proteins 
and nucleic acids as well as the synthesis of proteins.
Chlorine and products of chlorine do have broader spectrum of activity but 
they also leave behind toxic residues. They however are not affected by hardness 
of water, are less expensive and do possess faster onset of action [78]. They tend 
to possess activity on organisms fixed to surfaces and biofilms [79] with accompa-
nied low risk of toxicity [80]. Its mechanism of antimicrobial action is associated 
with hypochlorous acid (HOCl) it yields. When HOCl dissociates, it produces 
hypochlorite ion (OCl−) which has reduced antimicrobial activity and the process 
is pH-dependent [81]. It has not been mechanistically established how chlorine 
specifically kills microorganisms. However, chlorine tends to cause oxidation 
of sulfhydryl enzymes and amino acids leading to loss of intracellular contents 
with reduced nutrition uptake by cells. Also, chlorine tends to reduced adenosine 
triphosphate production as well as inhibition of DNA synthesis and increased DNA 
destruction [81]. A number of these process may account for the mechanism of 
antimicrobial action of chlorine [82].
4.4 Oxidizing agents
Peroxyacetic acid (1), chlorine dioxide (2) (Figure 2), and hydrogen per-
oxide have similar mechanism of antimicrobial action (chemical oxidation of 
cellular components), but they do vary greatly in their efficacy against micro-
organisms [83, 84]. Biochemically, there is significant variations in these agents 
with resultant variation in their outcomes on macromolecules. This attests to 
the variations in their biocidal activity, most especially between liquid and gas 
peroxide [84].
Administration of hydrogen peroxide results in the production of hydroxyl free 
radicals which attack lipid membranes, DNA and essential cell components leading 
to cell death. Aerobic organisms and facultative anaerobes tend to produce catalase 
and these enzymes offer protective benefits from hydrogen peroxide by catalyzing 
its conversion to water and oxygen. Such protective benefits are compromised by 
the concentrations of oxidizing agents administered as disinfectant [85]. Peracetic 
acid, which has rapid action on all microorganisms, does not yield any harm-
ful products when it is broken down and is easily cleared from organic materials 
without leaving behind any residues [86]. In addition to its potent activity in the 
presence of organic matter, it retains sporicidal activity even at low temperatures. 
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However, its specific mechanism of antimicrobial action has not been unraveled 
although postulated to be working in the same manner as other oxidizing agents. 
Hence possibly through oxidation of sulfhydryl and sulfur bonds in proteins, 
enzymes and other cellular metabolites [85].
4.5 Phenolic compounds
Phenolic compounds are produced from structural modification of phenol by 
addition of alkyl, phenyl, benzyl groups, and halogen as substituent on the aromatic 
ring. o-Phenylphenol (1) and o-benzyl-p-chlorophenol (2) are commonly employed 
phenol derivatives in disinfectants. Phenolic compounds tend to have enhanced 
antimicrobial potential than phenol [87].
Figure 3. 
Phenolic antibacterial chemicals.
Figure 4. 
Quaternary ammonium compounds with antibacterial activity.
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Phenol acts as a penetrating and disrupting molecule on cell walls of organisms 
as well as increase precipitation in important proteins within cells leading to cell 
death at high concentrations. However, phenol and high molecular weight phenolic 
compounds tend to kill bacteria cells via enzyme inactivation and compromising of 
cell wall at lower concentration (Figure 3) [88].
4.6 Quaternary ammonium compounds
One of the most used disinfectants is the quaternary ammonium compounds. 
When contaminated quaternary ammonium compounds are employed in patient-
care supplies, they contribute to significant proportion of its associated infections 
[89]. Gram-negative bacteria are documented to survive in this group of disinfec-
tants [90].
The quaternary compounds are ammonium-derived moieties with nitrogen 
atom with a valence of 5. There are four alkyl or heterocyclic radical substitutes 
and a fifth halide, sulfate or similar radical substitute in the structure [91]. Some 
of these quaternaries include alkyl dimethyl benzyl ammonium chloride (1), 
alkyl didecyl dimethyl ammonium chloride (2), and dialkyl dimethyl ammonium 
chloride (3) (Figure 4). The innovative quaternary ammonium compounds (i.e., 
fourth generation), referred to as twin-chain or dialkyl quaternaries (e.g., didecyl 
dimethyl ammonium bromide (4) and dioctyl dimethyl ammonium bromide (5) 
(Figure 4)), have been reported to be active even in hard water and can withstand 
anionic residues [92]. Quaternaries are believed to be bactericidal due to their 
ability to inactivate energy-producing enzymes and also denature and disrupt cell 
proteins and membrane respectively [91, 92].
5. Conclusion
A multidisciplinary approach to antimicrobial drug discovery, involving the 
generation of novel molecular diversity from natural product sources, combined 
with total and combinatorial synthetic methodologies, and including the manipula-
tion of biosynthetic pathways will continue to provide the best approach to antibi-
otic discovery and development and also overcome the challenges associated with 
antimicrobial resistance.
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